NEW YORK, September 22, 2015 /PRNewswire/ --
Equity Research Institute has initiated coverage on the
following equities: HCA Holdings Inc. (NYSE: HCA), Tenet Healthcare
Corporation (NYSE: THC), Community Health Systems Inc. (NYSE: CYH),
BioScrip Inc. (NASDAQ: BIOS) and DaVita HealthCare Partners Inc.
(NYSE: DVA). Free research report on HCA Holdings can be accessed
at https://www.erionline.net/HCA.pdf. On Monday, September 21, 2015, the NASDAQ Composite
ended at 4,828.96, up 0.04%, the Dow Jones Industrial Average
advanced 0.77%, to finish the day at 16,510.19 and the S&P 500
closed at 1,966.97, up 0.46%. The gains were broad based as seven
out of nine sectors ended the session in positive. Register for
your complimentary reports at the links given below.
HCA Holdings Inc.'s stock edged 0.29% lower, to close the day at
$82.24. The stock recorded a trading
volume of 3.45 million shares, above its three months average
volume of 3.24 million shares. Over the last one month and over the
past three months, HCA Holdings Inc.'s shares have fallen by 5.53%
and 2.69%, respectively. However, the stock has advanced 12.06%
since the start of this year. The company's shares are trading
3.23% above their 200-day moving average. Additionally, HCA
Holdings Inc. traded at a PE ratio of 16.85 and has a Relative
Strength Index (RSI) of 35.24. Sign up and read the free notes on
HCA at:
https://www.erionline.net/HCA.pdf
On Monday, shares in Tenet Healthcare Corp. recorded a trading
volume of 1.72 million shares, lower than their three months
average volume of 1.94 million shares. The stock ended the day
1.64% lower at $43.77. Shares of the
company traded at a PE ratio of 84.17. Tenet Healthcare Corp.'s
stock has plummeted 12.44% in the last one month, 16.21% in the
previous three months and 13.62% on YTD basis. The company is
trading below its 50-day and 200-day moving averages by 16.69% and
13.02%, respectively. Furthermore, shares of Tenet Healthcare Corp.
have an RSI of 26.09. The complimentary notes on THC can be
downloaded in PDF format at:
https://www.erionline.net/THC.pdf
Community Health Systems Inc.'s stock lost 1.51%, to close
Monday's session at $48.11. The stock
recorded a trading volume of 1.69 million shares, close to its
three months average volume of 1.65 million shares. Over the last
one month and the previous three months, Community Health Systems
Inc.'s shares have declined 14.94% and 14.91%, respectively.
Additionally, the stock has lost 10.78% since the start of this
year. The company is trading 14.58% and 10.23% below its 50-day and
200-day moving averages, respectively. Furthermore, Community
Health Systems Inc.'s stock traded at a PE ratio of 13.82 and has
an RSI of 28.29. Register for free on Equity Research Institute and
access the latest research on CYH at:
https://www.erionline.net/CYH.pdf
BioScrip Inc.'s stock finished Monday's session 0.68% lower at
$2.93. A total of 1.24 million shares
were traded, which was close to its three months average volume of
1.25 million shares. Over the previous three months and since the
beginning of 2015, BioScrip Inc.'s shares have plummeted 23.70% and
58.08%, respectively. However, the stock has surged 62.78% in the
last one month. The company's shares are trading above their 50-day
moving average by 19.06%. BioScrip Inc.'s stock has an RSI of
70.42. The complete research on BIOS is available for free at:
https://www.erionline.net/BIOS.pdf
On Monday, shares in DaVita HealthCare Partners Inc. ended the
session 1.37% higher at $76.02. The
stock reported a trading volume of 1.59 million shares, above its
three months average volume of 1.17 million shares. Shares of the
company traded at a PE ratio of 36.72. DaVita HealthCare Partners
Inc.'s shares have declined 3.20% in the last one month and 7.44%
in the previous three months. However, the stock has gained 0.37%
on YTD basis. The company is trading 2.52% below its 50-day moving
average and 3.36% below its 200-day moving average. Moreover,
shares of DaVita HealthCare Partners Inc. have an RSI of 48.49.
Free in-depth research on DVA is available at:
https://www.erionline.net/DVA.pdf
--
About Equity Research Institute:
Equity Research Institute ("ERI") produces regular sponsored and
non-sponsored reports, articles, stock market blogs, and popular
investment newsletters covering equities listed on NYSE and NASDAQ
and micro-cap stocks. ERI has two distinct and independent
departments. One department produces non-sponsored analyst
certified content generally in the form of press releases, articles
and reports covering equities listed on NYSE and NASDAQ and the
other produces sponsored content (in most cases not reviewed by a
registered analyst), which typically consists of compensated
investment newsletters, articles and reports covering listed stocks
and micro-caps. Such sponsored content is outside the scope of
procedures detailed below.
ERI has not been compensated; directly or indirectly; for
producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by
a writer (the "Author") and is fact checked and reviewed by a third
party research service company (the "Reviewer"). Rohit Tuli, a CFA® charter holder (the
"Sponsor"), provides necessary guidance in preparing the document
templates. The Reviewer has reviewed and revised the content, as
necessary, based on sound investment judgment and publicly
available information which is believed to be reliable. The
Reviewer and the Sponsor have not performed any independent
investigations or forensic audits to validate the information
herein. Unless otherwise noted, any content outside of this
document has no association with the Author, the Reviewer, or the
Sponsor (collectively referred to as the "Production Team") in any
way. The Production Team is compensated on a fixed monthly basis
and do not hold any positions of interest in any of the securities
mentioned herein.
NO WARRANTY
ERI, the Author, the Reviewer and the Sponsor (collectively
referred to as the "Publishers") are not responsible for any error
which may be occasioned at the time of printing of this document or
any error, mistake or shortcoming. No liability is accepted by the
Publishers whatsoever for any direct, indirect or consequential
loss arising from the use of this document. The Publishers
expressly disclaim any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance
placed on the information in this document. Additionally, the
Publishers do not (1) guarantee the accuracy, timeliness,
completeness or correct sequencing of the information, or (2)
warrant any results from use of the information. The included
information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or
a solicitation of an offer to buy or sell the securities mentioned
or discussed, and is to be used for informational purposes only.
Please read all associated disclosures and disclaimers in full
before investing. Neither ERI nor any party affiliated with us is a
registered investment adviser or broker-dealer with any agency or
in any jurisdiction whatsoever. To download our report(s), read our
disclosures, or for more information, visit
http://www.erionline.net.
RESTRICTIONS
ERI is not available to residents of Belarus, Cuba, Canada,
Iran, North Korea, Sudan, Syria
or Somalia.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE www.erionline.net